On April 26, 2018, Alder Biopharmaceuticals, Inc.'s Board of Directors appointed Jeremy C. Green to serve as a Class III director to serve until the Company’s 2020 annual meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal. In connection with Jeremy C. Green's appointment to the Company's Board of Directors, Jeremy C. Green and the Company entered into an indemnity agreement in the same form as the Company's standard form of indemnity agreement with its other directors.